Cargando…
A Bioengineered In Vitro Model to Assess AAV-Based Gene Therapies for Cyclic GMP-Related Disorders
The emergence of efficient viral vectors derived from adeno-associated viruses (AAV) has led many groups to develop gene therapies for inherited monogenic diseases, such as retinal dystrophies. To evaluate the potency of new gene therapy vectors in a preclinical context, it is common to use animal m...
Autores principales: | Pavlou, Marina, Babutzka, Sabrina, Michalakis, Stylianos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101586/ https://www.ncbi.nlm.nih.gov/pubmed/35562929 http://dx.doi.org/10.3390/ijms23094538 |
Ejemplares similares
-
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
por: Pavlou, Marina, et al.
Publicado: (2021) -
Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022) -
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders
por: El Andari, Jihad, et al.
Publicado: (2022) -
Retinal Cyclic Nucleotide-Gated Channels: From Pathophysiology to Therapy
por: Michalakis, Stylianos, et al.
Publicado: (2018) -
It's cold, mom! It's cyclic GMP
por: Kuhn, Michaela
Publicado: (2015)